Korean Market
MATR
CXI Healthcare Technology Group
★★★

CXI Healthcare Announces 5.5M Share Third-Party Rights Issue, Diluting Existing Shares by 49% with 1-Year Lock-Up

 
EXCH
CXI Healthcare Technology Group
★

CXI Healthcare Technology Group Limited Trading Suspension Lifted After Capital Reduction and Reverse Stock Split, Investors Should Exercise Caution Despite Price Support Attempt

 
OWNR
CXI Healthcare Technology Group
★★★

LIN JINSHENG Boosts CXI Healthcare Stake to 43.7% Massive Third-Party Allotment Dilutes Existing Shareholders

 
OWNR
CXI Healthcare Technology Group
★★

LIN JINSHENG's Third-Party Allotment Boosts Stake to 46.03%... Massive Dilution and Control Consolidation

 
EXCH
CXI Healthcare Technology Group
★★

CXI Healthcare Technology Group Limited Raises 7.3 Billion Won via Dilutive Rights Offering to Largest Shareholder, Concerns Over Shareholder Value Dilution and Stock Drop

 
EXCH
CXI Healthcare Technology Group
★

Record Date Set for Annual General Meeting, Limited Impact on Shareholder Value

 
MATR
CXI Healthcare Technology Group
★

CXI Healthcare Announces 7.2 Billion Won Third-Party Allotment to CEO, Diluting 9.9% with Three-Year Lock-Up

 
OWNR
CXI Healthcare Technology Group
★

CXI Largest Shareholder LIN JINSHENG Maintains 22.17% Stake After 5:1 Stock Split, No Dilution Impact

 
OWNR
CXI Healthcare Technology Group
★

CXI Healthcare Technology Group 5-to-1 Stock Merger Maintains Major Shareholder Ruixing International Holdings Stake at 6.73% with Neutral Impact on Shareholder Value

 
OWNR
CXI Healthcare Technology Group
★

LIN JINSHENG's Shareholding Adjusts Due to Stock Consolidation, Ownership Percentage Unchanged

 
EXCH
CXI Healthcare Technology Group
★

CXI Healthcare Technology Group Completes 80% Par Value Reduction with No Change in Share Count

 
MATR
CXI Healthcare Technology Group
★★★

CXI Healthcare to Issue 49.5% Dilutive Rights Offering to Largest Shareholder, Raising Concerns for Shareholder Value

 
OTHR
CXI Healthcare Technology Group
★★

CXI Loses Only Independent Director, Board Independence Falls to Zero, Raising Governance Concerns

 
PERI
CXI Healthcare Technology Group
★★

CXI's Q3 Results Swing to Operating Loss, Dilution from Capital Raise and Capital Reduction Raise Shareholder Concerns

 
OTHR
CXI Healthcare Technology Group
★

Corrective Disclosure on Stock Option Grant Reflecting 5:1 Reverse Split - 500,000 shares, Exercise Price 5,000 won